Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Trinity Biotech ( (TRIB) ) just unveiled an update.
On August 7, 2025, Trinity Biotech announced the launch of its FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test, a significant advancement in maternal health diagnostics. This new testing service, developed in collaboration with Thermo Fisher Scientific, will be available through Trinity Biotech’s New York-based reference laboratory in Q3 2025. The test is designed to provide clinicians with critical insights for managing hypertensive disorders of pregnancy, potentially leading to significant cost savings and improved patient outcomes. This strategic milestone enhances Trinity Biotech’s position in the maternal health sector and reflects its commitment to addressing urgent healthcare needs.
Spark’s Take on TRIB Stock
According to Spark, TipRanks’ AI Analyst, TRIB is a Neutral.
Trinity Biotech’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues, high debt, and negative equity. The technical analysis provides some positive signals, but these are overshadowed by the poor financial health and negative valuation metrics. The absence of dividend yield and negative P/E ratio further weaken the stock’s investment appeal.
To see Spark’s full report on TRIB stock, click here.
More about Trinity Biotech
Trinity Biotech is a commercial-stage biotechnology company that focuses on diabetes management solutions and human diagnostics, including wearable biosensors. The company develops, acquires, manufactures, and markets diagnostic systems for the point-of-care and clinical laboratory segments, and has recently entered the wearable biosensor industry. Trinity Biotech’s products are used to detect infectious diseases and quantify Haemoglobin A1c and other chemistry parameters, and are sold directly in the United States and through international distributors in over 75 countries.
Average Trading Volume: 864,467
Technical Sentiment Signal: Sell
Current Market Cap: $14.99M
For a thorough assessment of TRIB stock, go to TipRanks’ Stock Analysis page.